ACX
Next-generation biocides for sustainable agriculture at scale
New York, United States · Founded 2024 · $15.5M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2024
- Website
- acxtherapeutics.com
- Total Funding
- $15.5M
- Last Round
- $15.0M Series AOct 2024
- Rounds
- 2
About
ACX is developing a new standard for precision agriculture technologies by providing sustainable, eco-friendly alternatives to chemical pesticides. Our mission is to transform agriculture through sustainable biological crop protection that increases yields while safeguarding the environment, farmers, and consumers.
Summary
ACX is an Agtech company based in New York, United States, founded in 2024. It has raised $15.5M in total across 2 rounds, most recently a $15.0M Series A round in Oct 2024. Investors include TRIREC and Y Combinator Continuity Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.